#CNBC Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”